Figure 1From: Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinomaImmunohistochemical expression of p501s on benign and malignant epithelium of prostate and non-prostatic tissues. A. Non-neoplastic prostatic tissue adjacent to malignant glands (NNT). B. Benign prostatic hyperplasia. C. High-grade prostatic intraepithelial neoplasia (PIN). D. Prostatic adenocarcinoma (PCA).Back to article page